STYRENIX PERFORMANCE | SUNIL HEALTHCARE | STYRENIX PERFORMANCE/ SUNIL HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 19.7 | -59.6 | - | View Chart |
P/BV | x | 5.9 | 1.1 | 521.9% | View Chart |
Dividend Yield | % | 4.1 | 0.0 | - |
STYRENIX PERFORMANCE SUNIL HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
STYRENIX PERFORMANCE Mar-24 |
SUNIL HEALTHCARE Mar-24 |
STYRENIX PERFORMANCE/ SUNIL HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,650 | 80 | 2,062.5% | |
Low | Rs | 714 | 46 | 1,564.1% | |
Sales per share (Unadj.) | Rs | 1,263.3 | 88.0 | 1,435.7% | |
Earnings per share (Unadj.) | Rs | 98.4 | -1.7 | -5,640.5% | |
Cash flow per share (Unadj.) | Rs | 119.4 | 4.2 | 2,847.1% | |
Dividends per share (Unadj.) | Rs | 98.00 | 0 | - | |
Avg Dividend yield | % | 8.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 410.9 | 66.6 | 617.4% | |
Shares outstanding (eoy) | m | 17.59 | 10.25 | 171.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.9 | 0.7 | 131.0% | |
Avg P/E ratio | x | 12.0 | -36.0 | -33.3% | |
P/CF ratio (eoy) | x | 9.9 | 15.0 | 66.0% | |
Price / Book Value ratio | x | 2.9 | 0.9 | 304.5% | |
Dividend payout | % | 99.5 | 0 | - | |
Avg Mkt Cap | Rs m | 20,786 | 644 | 3,226.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 672 | 129 | 519.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,222 | 902 | 2,463.8% | |
Other income | Rs m | 93 | 52 | 177.4% | |
Total revenues | Rs m | 22,314 | 954 | 2,338.7% | |
Gross profit | Rs m | 2,643 | 41 | 6,467.6% | |
Depreciation | Rs m | 368 | 61 | 604.3% | |
Interest | Rs m | 36 | 58 | 61.4% | |
Profit before tax | Rs m | 2,333 | -26 | -9,129.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 601 | -8 | -7,834.4% | |
Profit after tax | Rs m | 1,732 | -18 | -9,679.7% | |
Gross profit margin | % | 11.9 | 4.5 | 262.5% | |
Effective tax rate | % | 25.8 | 30.0 | 85.9% | |
Net profit margin | % | 7.8 | -2.0 | -393.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 6,944 | 625 | 1,111.3% | |
Current liabilities | Rs m | 2,566 | 573 | 447.7% | |
Net working cap to sales | % | 19.7 | 5.7 | 342.7% | |
Current ratio | x | 2.7 | 1.1 | 248.2% | |
Inventory Days | Days | 12 | 13 | 96.4% | |
Debtors Days | Days | 5 | 1,643 | 0.3% | |
Net fixed assets | Rs m | 3,432 | 960 | 357.5% | |
Share capital | Rs m | 176 | 103 | 171.5% | |
"Free" reserves | Rs m | 7,051 | 580 | 1,216.6% | |
Net worth | Rs m | 7,227 | 682 | 1,059.5% | |
Long term debt | Rs m | 97 | 203 | 48.0% | |
Total assets | Rs m | 10,379 | 1,585 | 654.8% | |
Interest coverage | x | 66.7 | 0.6 | 11,962.5% | |
Debt to equity ratio | x | 0 | 0.3 | 4.5% | |
Sales to assets ratio | x | 2.1 | 0.6 | 376.3% | |
Return on assets | % | 17.0 | 2.5 | 676.6% | |
Return on equity | % | 24.0 | -2.6 | -913.9% | |
Return on capital | % | 32.3 | 3.6 | 887.7% | |
Exports to sales | % | 0 | 17.7 | 0.0% | |
Imports to sales | % | 63.7 | 28.9 | 220.7% | |
Exports (fob) | Rs m | NA | 160 | 0.0% | |
Imports (cif) | Rs m | 14,154 | 260 | 5,438.1% | |
Fx inflow | Rs m | 18 | 160 | 11.1% | |
Fx outflow | Rs m | 14,154 | 260 | 5,438.1% | |
Net fx | Rs m | -14,137 | -101 | 14,044.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,163 | -154 | -1,404.6% | |
From Investments | Rs m | -880 | -101 | 869.6% | |
From Financial Activity | Rs m | -1,766 | 250 | -706.4% | |
Net Cashflow | Rs m | -483 | -5 | 9,507.9% |
Indian Promoters | % | 46.2 | 73.5 | 62.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 13.2 | 0.1 | 13,220.0% | |
FIIs | % | 3.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 53.8 | 26.5 | 203.1% | |
Shareholders | 45,882 | 6,507 | 705.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare STYRENIX PERFORMANCE With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES NAVIN FLUORINE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Ineos Styrolution | SUNIL HEALTHCARE | S&P BSE OIL & GAS |
---|---|---|---|
1-Day | -0.53% | 2.24% | -1.45% |
1-Month | -3.22% | -9.55% | -13.49% |
1-Year | 76.60% | 49.08% | 30.87% |
3-Year CAGR | 19.61% | 24.41% | 12.11% |
5-Year CAGR | 27.77% | 34.88% | 10.80% |
* Compound Annual Growth Rate
Here are more details on the Ineos Styrolution share price and the SUNIL HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of Ineos Styrolution hold a 46.2% stake in the company. In case of SUNIL HEALTHCARE the stake stands at 73.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Ineos Styrolution and the shareholding pattern of SUNIL HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, Ineos Styrolution paid a dividend of Rs 98.0 per share. This amounted to a Dividend Payout ratio of 99.5%.
SUNIL HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Ineos Styrolution, and the dividend history of SUNIL HEALTHCARE.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.